Skip to main content
SRZN logo

SRZN · Surrozen, Inc. · Executive Compensation

Track SRZN — free
$28.46 -2.21 (-7.21%) At close · Nov 20 Q4 2022 earnings call transcript
Market Cap
$542.49M
Shares
19.06M
Volume · Nov 20 148.86K Avg daily vol (3M) 531.32K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Craig Parker $2,819,017
Charles Williams $1,518,919
Fiscal 2024
Executive Total
Craig Parker $1,520,085
Charles Williams $1,007,326
Yang Li $847,193
Fiscal 2023
Executive Total
Craig Parker $1,165,250
Wen-Chen Yeh $716,294
Charles Williams $675,526
Yang Li $576,732
Fiscal 2022
Executive Total
Craig Parker $1,895,450
Charles Williams $904,215
Wen-Chen Yeh $867,493
Yang Li $662,960
Fiscal 2021
Executive Total
Craig Parker $4,212,626
Wen-Chen Yeh $744,073
Charles Williams $635,236
Gad Soffer —
Fiscal 2020
Executive Total
Charles Williams $581,293
Craig Parker $553,500
Wen-Chen Yeh $497,560
Gad Soffer —

Executive changes

Person Change Filed
Shao-Lee Lin, M.D., Ph.D.
“Dr. Lin’s resignation was not because of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
Resigned 2026-01-30
Andrew Maleki Appointed 2025-11-07
Tim Kutzkey Appointed 2025-03-28
Tim Kutzkey, Ph.D.
“Dr. Kutzkey's resignation is not the result of any disagreement with us on any matter relating to our operations, policies or practices.”
Resigned 2024-07-01
Charles Williams Appointed 2024-02-07
Wen-Chen Yeh, M.D., Ph.D. Appointed 2023-07-19
Eric Bjerkholt Appointed 2023-04-05
Tim Kutzkey, Ph.D. Appointed 2021-08-17
Christopher Y. Chai Appointed 2021-08-17
Mace Rothenberg, M.D. Appointed 2021-08-17
David J. Woodhouse, Ph.D. Appointed 2021-08-17
Mary Haak-Frendscho, Ph.D. Appointed 2021-08-17
Shao-Lee Lin, M.D., Ph.D. Appointed 2021-08-17
Tim Kutzkey, Ph.D. Appointed 2021-08-17
Anna Berkenblit, M.D. Appointed 2021-08-17
Craig Parker Appointed 2021-08-17

Leadership

Key facts CIK 1824893 CUSIP 86889P208 13F (30d) 97 filings 93 filers Visit website Investor relations